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Strengths and limitations of this study
 ► This systematic review is the first to explore the use 
of tools to predict future self-harm/future suicide at-
tempts in an adolescent population
 ► A checklist combining the QUIPS and QUADAS-2 
tools was used to evaluate the quality of the includ-
ed studies
 ► High levels of heterogeneity meant that meta-analy-
sis was not possible
 ► Results of the study support other reviews in adult 
populations and highlights the need for further risk 
prediction work in this area
AbStrACt
Objective This systematic review aimed to evaluate 
the ability of risk tools to predict the future episodes of 
suicide/self-harm in adolescents.
Design Systematic review.
Data sources MEDLINE, EMBASE, CINAHL and PsycINFO 
were searched from inception to 3 March 2018.
Eligibility criteria for selecting studies Cohort studies, 
case–control studies and randomised controlled trials 
of adolescents aged 10–25 who had undergone risk 
assessment in a clinical setting following an episode of 
self-harm were included.
Data extraction and synthesis Two independent 
reviewers extracted data and assessed risk of bias. Data 
were grouped by tool and narrative synthesis undertaken, 
with studies appraised using a checklist combining the 
QUIPS (Quality In Prognosis Studies) and QUADAS-2 
(Quality Assessment of Diagnostic Accuracy Studies) tools.
results Of the 17 137 articles initially identified, 11 
studies evaluating 10 separate tools were included. The 
studies varied in setting, population and outcome measure. 
The majority of the studies were rated as having an 
unclear risk of bias, and meta-analysis was not possible 
due to high variability between studies.
The ability of the tools to correctly identify those 
adolescents going on to make a self-harm/suicide attempt 
ranged from 27% (95% CI 10.7% to 50.2%) to 95.8% 
(95% CI 78.9% to 99.9%). A variety of metrics were 
provided for 1–10 points increases in various tools, for 
example, odds and HRs.
Conclusions This systematic review is the first to explore 
the use of assessment tools in adolescents. The predictive 
ability of these tools varies greatly. No single tool is 
suitable for predicting a higher risk of suicide or self-harm 
in adolescent populations.
PrOSPErO registration number CRD42017058686
IntrODuCtIOn
Self-harm and suicide are serious prob-
lems in children, adolescents and young 
people,1–3 with the highest rates seen in those 
aged 16–24 years.4 5 The term self-harm can 
be used to refer to acts of self-poisoning or 
self-injury (eg, cutting, scratching, breaking 
bones and burning) carried out intentionally 
regardless of motive or suicidal intent.6 Repe-
tition of self-harm is common, with 15%–25% 
of adolescents, treated at hospital for an 
episode of self-harm returning for treatment 
within 12 months.2 7
There is a strong association between 
self-harm and risk of future suicide,6 8 with 
approximately 50% of adolescents who die 
by suicide having previously self-harmed,9 
and self-harm increasing the risk of death by 
suicide approximately tenfold.10 The 6-month 
period, following an episode of self-harm, has 
been identified as when this risk of death is 
highest.11 Despite the association, there are 
important differences between acts of self-
harm and suicide attempts. The motivations 
behind suicide attempts include wanting to 
end one’s life, whereas motivations behind 
self-harm are more typically related to attenu-
ating negative emotions and feelings.12 There 
are also key differences with suicide attempts 
tending towards high lethality, infrequent 
occurrence and single method use only, 
whereas acts of self-harm contrast with single 
or multiple methods of low lethality and 
repetition.13
Predicting suicide and repetition of self-
harm in adolescents is a challenge as it is 
usually a secretive and hidden behaviour, and 
there is no single risk factor for adolescent 
self-harm.1 14–16 Additionally, in this popu-
lation, suicide is a rare event with low prev-
alence (5.8 per 100 000 for the 15–19 years 
age group, and 9.5 per 100 000 for the 20–24 
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years age group in the UK in 201517 making risk predic-
tion difficult.
The UK guidelines for the management of self-harm in 
those aged over 8 years recommend that all patients who 
present with self-harm should undergo comprehensive 
psychosocial assessment including assessing the risk of 
repetition of self-harm or suicide, as well as a full mental 
health and social needs assessment.18–20 Risk scales/tools 
(from here on referred to a tools) tend to be a key part 
of this assessment, however, there is currently only a 
small amount of evidence available regarding their use 
and effectiveness, and no guidance as to which to use, 
or which is best for particular populations or settings.18 21 
The UK guidelines suggest that these risk tools should 
not be used alone to determine future risk or to make a 
decision on when to offer treatment.18–20 There is a large 
variation in the type and format of risk tools being used 
across the UK.22–24 A survey of 32 English hospitals found 
that over 20 different risk tools were in use, many of these 
were locally developed, highlighting a lack of consistency 
of practice.21
The content is variable from tool to tool with some only 
assessing a few parameters and others assessing a more 
extensive range. Adult tools may not be appropriate for 
use with adolescents due to either inappropriate ques-
tions being asked, or important areas specific to the age 
group not being assessed.
Previous systematic reviews of risk assessment tools used 
to predict future self-harm or suicide following self-harm 
in an adult population have been conducted,3 25–27 and 
none were able to conclude that any one tool performed 
better than another or was more useful for predicting 
future self-harm or suicide attempts.
While adult populations have been considered, there 
is currently no systematic review examining risk tools in 
an adolescent population, a key age group affected by 
self-harm and suicide. A review is required specifically 
focusing on this age group to allow greater understanding 
of the use of risk assessments in this population.
The wide variety in the type of risk tools being used 
across hospitals and current lack of guidance surrounding 
their use in particular patient groups and settings warrants 
further investigation to improve and standardise patient 
care. This review contributes to the body of evidence 
for self-harm and suicide prediction and prevention to 
ensure that informed decisions can be made regarding 
predication of future risk and future research.
Objectives
This systematic review aimed to evaluate the ability of risk 
assessment tools to predict future episodes of self-harm 
or suicide in adolescents and young adults presenting to 
clinical services with an episode of self-harm or attempted 
suicide. To achieve this aim, the review asked the following 
question:
How accurately do risk assessment tools/scales predict 
which adolescent and young adults will go on to self-harm in 
the future, make a future suicide attempt or die by suicide?
MEthODS
Search strategy
The following bibliographic databases were searched 
from inception to March 2018 with no language restric-
tions: MEDLINE, EMBASE, CINAHL, PsycINFO and 
Open Grey. Searches used index and free-text terms 
related to self-harm, suicide, adolescents and risk assess-
ment. Terms were combined using the appropriate OR 
and AND operators (see MEDLINE search strategy in 
online supplementary appendix 1).
Selection/inclusion criteria
Study design
Prospective and retrospective cohort studies, case–
control studies and randomised controlled trials testing 
assessment tools.
Patient group
Adolescents and young people aged 10–25 who have 
self-harmed or attempted suicide who have presented 
to clinical services or have been treated by a clini-
cian following an episode of self-harm or attempted 
suicide. Studies also containing older populations were 
included if data for 10–25 years were presented sepa-
rately. Studies on a wider age range were included if 
the majority of the sample (>50%) had self-harmed or 
attempted suicide.
WHO defines adolescence as being between 10 and 
19 years28, however, in the literature the upper limit for 
adolescents can range from 18 to 25 years.1 In an attempt 
to include all relevant data in this review, reflecting this 
and that self-harm is rare before the age of 12, a broad 
range of 11–25 years will be included.29
Interventions
Any risk assessment.
Timing
No restriction was placed on length of follow-up so long 
as the outcomes occurred after the risk assessment was 
carried out.
Setting
Studies with the risk assessment carried out within a clin-
ical setting or by a clinician were included. This could 
have been an inpatient or outpatient facility or as part of 
a home treatment programme.
Outcome
Self-harm and/or attempted suicide or completed 
suicide. It was acknowledged that these may be recorded 
individually or they may be grouped together (eg, repeat 
self-harm and attempted suicide may have been classed as 
the same event).
Study selection
Due to the large number of records, 10% of titles and 
abstracts were initially screened by two reviewers inde-
pendently using predefined criteria based on the target 
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population and outcome to identify potentially relevant 
articles. After discussion and consideration of reasons 
for any disagreements, the remaining titles and abstracts 
were screened by one reviewer.
The full text of the potentially relevant articles was 
obtained and assessed against the full inclusion criteria. 
Endnote V.X7 software (Clarivate Analytics) was used to 
record study selection decisions, and reasons for exclu-
sion were noted.
Data extraction strategy
Data extracted included: study characteristics (dura-
tion, start and end date, country and setting), partic-
ipant characteristics (number, average age, gender, 
ethnicity, socioeconomic details and comorbidities), any 
reported subgroups of participants, tool used, if tool is 
validated, data collection method, outcome(s) measured 
(eg, repeat self-harm), method of outcome assessment, 
total number followed up, lost to follow-up number and 
reasons, number of events for each outcome and data 
on measures of association between assessment tool and 
outcome (eg, relative risk (RR), sensitivity and specificity) 
along with attendant precision (95% CI, p values) or raw 
data to calculate these. Unadjusted and adjusted data 
along with factors adjusted for were recorded. Where 
data were not reported, the corresponding author of the 
article was contacted by email. A follow-up email was sent 
if no response was received.
Quality assessment strategy
Risk of bias assessment of included studies used rele-
vant elements of QUIPS30 31 and QUADAS-2,32 checklists 
suitable for prognostic and diagnostic tests, respectively. 
QUIPS covers areas of possible bias in the prognostic 
factor studies, such as study participation, attrition and 
outcome measurement, and QUADAS-2 covers areas of 
possible bias in diagnostic test accuracy studies, such as 
patient selection, index test and reference standard used. 
Studies reporting prognostic model development were 
assessed on a further four criteria identified from exam-
ining the quality assessment conducted for a systematic 
review of prognostic models.33 These criteria include 
assessment of statistical methods used and methods of 
dealing with confounding factors.
Study selection, risk of bias assessment and data 
extraction were undertaken by two reviewers inde-
pendently, and any disagreements resolved by discussion 
with referral to a third reviewer if required.
Methods of data analysis/synthesis
A narrative synthesis was carried out presenting infor-
mation from all included studies to explore similari-
ties, differences and findings within and between them. 
Where possible studies were grouped and analysed by 
tool.
Data synthesis
For each tool, outcome (self-harm; suicide) and outcome 
measure (OR, HR; sensitivity/specificity) grouping, 
contributing studies and data were assessed for clinical 
and methodological homogeneity. This informed a deci-
sion that meta-analysis was not appropriate, and there-
fore, data have been presented narratively.
Patient and public involvement
No patients or public were involved in this review.
rESultS
Search results
A total of 17 137 potentially relevant records were iden-
tified through the literature search. After removal of 
duplicate records and screening for relevance to the 
review, inclusion criteria were applied to 103 full-text 
articles. Eleven studies34–44 were included in the review 
and 92 excluded due to not meeting criteria for popula-
tion (37 articles), study design (25), outcome (7), use of 
an assessment tool (15) and separately presenting data 
on an adolescent subgroup (8). Two of these last eight 
studies presented baseline, but not outcome, data for an 
adolescent subgroup so the authors were contacted to try 
to obtain these data. No response was received so these 
papers remain excluded (see figure 1).
Study characteristics
The 11 included studies comprised 8 prospective35 36 38 40–44 
and 3 retrospective34 37 39 cohort designs and evaluated 10 
tools (table 1); eight tools were specifically for self-harm/
suicide assessment and two were for hopelessness and 
depression. Four studies attempted to develop a predic-
tion model.36 37 41 44 No trials evaluating the impact of 
using a tool were identified.
A total of 2554 participants were included, ranging from 
10 to 24 years of age who were followed up for between 3 
and 18 months. Three studies contained participants that 
had all presented with self-harm/suicide attempt,34 36 43 
and the remainder had mixed populations where >50% 
presented with self-harm/suicide attempt.35 37–42 44 The 
proportion of each study population that presented with 
self-harm/suicide attempt is presented in table 1. As a 
result of the studies with mixed populations, 1818 of the 
total 2554 participants presented with self-harm/suicide.
The studies were carried out across a variety of settings 
in the UK36 42 and USA.34 35 37–41 43 44 Four took place 
in an emergency department,34 37–39 four in inpatient 
units,35 40 41 44 one each in an open treatment trial,43 a 
home setting36 and clinic sessions for a mixed inpatient/
outpatient population.42
The 10 tools varied in length from three questions 
(Self-Assessed Expectation of Suicide Risk Scale)37 to 
93 questions (Self-Injurious Thoughts and Behaviours 
Interview, SITBI)35; the latter being unusually long as 
all other tools evaluated had ≤30 questions. The content 
assessed by the tools greatly varied. For example, eight 
of the tools asked about suicidal ideation, however, only 
two asked about previous self-harm. For full details of the 
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Figure 1 PRISMA flow diagram detailing the search process 
for included studies. PRISMA, Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses.
tool content and length, please see the data presented in 
online supplementary appendix 2.
Across the studies, a selection of metrics to report outcome 
data were used. These include OR (adjusted and unad-
justed), RR, HR (adjusted and unadjusted), and predictive 
validity statistics such as sensitivity and specificity. Online 
supplementary figure 1 details the full range of outcome 
measures, subgroups reported and factors adjusted for (if 
relevant) for each tool across all the studies.
Quality assessment
In general, reporting of the studies could have been better. 
For example, completeness of follow-up was rarely reported, 
and neither were details regarding whether the method 
of identifying the outcome (self harm/suicide attempt) 
was interpreted without knowledge risk assessment tool 
findings.
Only three of the studies34 36 43 comprised a population 
where all patients presented with an episode of self-harm 
or a suicide attempt. In the remaining studies,35 37–42 44 the 
proportion ranged from 51% to 79% but data were not 
separately reported for this group in these mixed popula-
tion studies.
The four studies reporting prognostic models varied in 
quality.36 37 41 44 All four were at the model development 
stage and only one of these was assessed as having a low 
risk of bias due to under reporting of details in the others.
Table 2 details the quality assessment undertaken on all 
11 included studies.
FInDIngS
The findings from all included studies are presented by 
outcome measure (HR, OR and area under the curve 
(AUC) from receiver operator characteristic curves) in 
table 3 and predictive validity statistics (sensitivity, spec-
ificity, positive predictor value and negative predictor 
value) in table 4. Sensitivity can be defined as the propor-
tion of positives that are correctly identified as positive, 
and specificity as the proportion of negatives that are 
correctly identified as negative. Positive predictive value 
(PPV) tells you the proportion of positive test results that 
truly are positive, and negative predictive value (NPV) tells 
you the proportion of test results that are truly negative. 
PPV and NPV, unlike sensitivity and specificity, are depen-
dent on disease prevalence, so careful consideration of 
the disease prevalence must be made when applying PPV 
and NPV values to a different clinical population.45
Predicting future self-harm
Three studies, assessing four tools, contributed data for 
predicting future self-harm.
The Self-Injury Implicit Association Test (SI-IAT)35 
scores were not statistically significantly predictive of 
repeat self-harm at 3 months, (unadjusted OR 3.10, 95% 
CI 0·39 to 9.94, p≥0·05).
The SITBI35 scores were found to be statistically signifi-
cantly predictive of repeat self-harm at 3 months follow-up 
(adjusted OR 1.82, 95% CI 1.25 to 2.65, p=0.002). This 
study (evaluating both SI-IAT and SITBI) was assessed as 
having a high risk of bias, mostly due to poor reporting.
At 6 months follow-up, the accuracy of the Suicide 
Ideation Questionnaire (SIQ)36 to classify a patient as 
high or low risk for self-harm repetition was: sensitivity 
27.3%, specificity 99.2%, PPV 85.7% and NPV 85.6%. This 
tool performed poorly at identifying high-risk patients, 
but performed well at identifying low-risk patients.
The predictive validity of the Self-Harm Questionnaire 
(SHQ)42 was reported at 3 months. This was: sensitivity 
94.7%, specificity 34.6%, PPV 25.4% and NPV 96.6%. 
This tool performed well at identifying high-risk patients, 
but performed poorly at identifying low-risk patients.
PrEDICtIng FuturE SuICIDE AttEMPt
Eight studies reporting seven tools for predicting future 
suicide attempt.
The predictive ability of the Ask Suicide Screening 
Questions (ASQ)34 was reported at 6 months as: sensitivity 
95.8%, specificity 5.8%, PPV 16.8% and NPV 87.5%.
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Table 1 Methodological characteristics and outcomes of included studies
Outcome repeat self-harm
Study ID Study design Tool/ 
scale
Context Sampling and 
population
No % with 
self-harm 
or suicide 
attempt
Mean age 
in years 
(SD)
Outcome 
events
Outcome 
measure
Length of 
follow-up
Method of 
outcome 
identification
Cha et al35 Prospective 
cohort
SI-IAT, 
SITBI
Inpatient unit 
in Boston, 
USA
Adolescents 
recently 
admitted to 
a psychiatric 
inpatient unit
(age 10–17)
123 55.3 14.8 (1.5) Not stated Adjusted 
OR
3 months Not stated
Chitsabesan 
et al36
Prospective 
cohort
SIQ Home setting 
in Manchester, 
UK
Consecutive 
referrals of 
overdoses 
to CAMHS 
teams
(under 16)
162 100 14.5 (1.2) 23 Sensitivity 
and 
specificity
6 months Not stated
Ougrin and 
Boege42
Prospective 
cohort
SHQ Clinical 
sessions in 
South London 
and Maudsley 
NHS 
Foundation 
Trust for in/
outpatients
In/outpatients 
having clinical 
sessions
(age 12–17)
100 71 15.1 (1.7) 19 Sensitivity 
and 
specificity
3 months Clinical 
record review, 
searching for 
self-harm
Outcome suicide attempt
Study ID Study design Tool/ 
scale
Context Sampling and 
population
No % with 
self-harm 
or suicide 
attempt
Mean age 
in years 
(SD)
Outcome 
events
Outcome 
measure
Length of 
follow-up
Method of 
outcome 
identification
Ballard et al34 Retrospective 
cohort
ASQ A&E 
department 
in Baltimore, 
USA
Consecutive 
patients 
presenting 
to A&E with 
suicide 
ideation or 
attempt
(age 8–18)
230 100 14.0 (2.2) 24 Sensitivity 
and 
specificity
6 months Hospital's 
electronic 
health record 
database, 
searched for 
suicide attempt
Study ID Study design Tool/ 
Scale
Context Sampling and 
population
No % with 
self-harm 
or suicide 
attempt
Mean age 
in years 
(SD)
Outcome 
events
Outcome 
measure
Length of 
follow-up
Method of 
outcome 
identification
Czyz et al37 Retrospective 
cohort
SAESRS,
C-SSRS
Psychiatric 
emergency 
department of 
Midwestern 
US university 
hospital
Patients 
seeking 
emergency 
psychiatric 
services
(age 13–24)
340 59 17.6 (3.3) 39 Adjusted 
HR, AUC
Mean 
follow-up 
486.7 days 
(range 
12–18 
months)
Hospital's 
electronic 
health record 
database, 
searched for 
suicide attempt
Gipson et al38 Prospective 
cohort
C-SSRS Psychiatric 
emergency 
department of 
Midwestern 
US university 
hospital
Patients 
seeking 
emergency 
psychiatric 
services
(age 13–17)
178 50.6 15.3 (1.3) 12 Unadjusted 
OR
12 months Hospital's 
electronic 
health record 
database, 
searched for 
suicide attempt
Horowitz et 
al39
Retrospective 
cohort
C-SSRS Psychiatric 
emergency 
department of 
Midwestern 
US university 
hospital
Patients 
seeking 
emergency 
psychiatric 
services
(age 15–24)
473 51.6 19.3 (2.9) 147 Adjusted 
OR
18 months Hospital's 
electronic 
health record 
database, 
searched for 
suicide attempt
King et al40 Prospective 
cohort
SIQ-JR Inpatient unit 
in Michigan, 
USA
Patients 
hospitalised 
for acute 
suicide risk 
(age 13–17)
354 79 15.6 (1.3) 60 Relative risk 12 months DISC-IV Mood 
disorders 
module of the 
diagnostic 
interview 
schedule for 
children
Continued
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Outcome repeat self-harm
King et al41 Prospective 
cohort
SIQ-JR, 
BHS, 
CDRS-R
Inpatient unit 
in Michigan, 
USA
Patients 
hospitalised 
for acute 
suicide risk 
(age 13–17)
352 76.1 15.6 (1.3) 63 Unadjusted 
HR, 
adjusted 
HR
12 months DISC-IV Mood 
disorders 
module of the 
diagnostic 
interview 
schedule for 
children
Posner et al43 Prospective 
cohort
C-SSRS Open 
treatment 
trial for 
adolescents 
suicide 
attempters in 
USA
Adolescents 
who had 
made a 
suicide 
attempt 45 
days before 
enrolment
(age 12–18)
124 100 15.8 (1.5) 24 Unadjusted 
OR
6 months Columbia 
Suicide History 
Form
Yen et al44 Prospective 
cohort
SIQ Inpatient unit 
in USA
Adolescents 
receiving 
inpatient 
treatment, 
admitted 
for elevated 
suicide risk
119 >62.2 15.3 (1.4) 37 Unadjusted 
HR, 
adjusted 
HR
6 months Adolescent 
Longitudinal 
Interval Follow-
Up Evaluation
A&E, Accident and Emergency; ASQ, Ask Suicide Screening Questions; AUC, area under the curve; BHS, Beck Hopelessness Scale; CDRS-R, Children’s Depression Rating Scale-
Revised; C-SSRS, Columbia-Suicide Severity Rating Scale;DISC-IV, Diagnostic Interview Schedule for Children; NHS, National Health Service; SAESRS, Self-Assessed Expectations 
of Suicide Risk Scale; SHQ, Self-Harm Questionnaire; SI-IAT, Self-Injury Implicit Association Test; SIQ, Suicide Ideation Questionnaire; SIQ-JR, Suicide Ideation Questionnaire-Junior; 
SITBI, Self-Injurious Thoughts and Behaviours Interview.
Table 1 Continued
The SIQ-Junior (SIQ-JR) was evaluated in two studies, 
one reported RR40 and the other reported adjusted and 
unadjusted HRs.41 For every 1-point increase in SIQ-JR 
score, the RR of no future attempt was 0.93.40 No CIs 
or p value were stated. For every 10-point increase in 
the SIQ-JR score, the unadjusted HR of future suicide 
attempt was 1.30 (95% CI 1.14 to 1.48, p≤0.001).41 
A subsequent multivariate regression model then 
reported an adjusted HR of 1.23 (95% CI 1.08 to 1.40, 
p=0.003).
The Columbia-Suicide Severity Rating Scale (C-SSRS) 
was evaluated by four studies,37–39 43 reporting adjusted and 
unadjusted ORs, adjusted HR and AUC. Three of these 
studies reported outcomes for the C-SSRS, and the two 
subscales (severity and intensity) that the C-SSRS comprises.
The unadjusted OR ranged from 1.09 (95% CI 1.01 
to 1.17) to 3.85 (95% CI 1.07 to 13.86) for every 1-point 
increase in C-SSRS score, and the adjusted OR ranged 
from 1.15 (95% CI 1.03 to 1.29) to 1.51 (95% CI 1.24 to 
1.84) for every 1-point increase in C-SSRS score.
For the SIQ, unadjusted and adjusted HRs were 
reported.44 In the univariate regression conducted, a statis-
tically significant HR of 1.01 (95% CI 1.00 to 1.02, p≤0.05) 
for the dichotomised (high/low suicidal intent) SIQ score 
was reported, however, after the multivariate analysis, 
despite the HR being the same at 1.01 (95% CI 1.00 to 1.02, 
p≥0.05), it was no longer statistically significant.
For the Beck Hopelessness Scale,41 an unadjusted HR 
of 1.51 (95% CI 1.22 to 1.87, p≤0.001) was reported for a 
5-point increase in the scale.
For the Children’s Depression Rating Scale-Revised41, 
an unadjusted HR of 1.29 (95% CI 1.10 to 1.52, p=0.002) 
for a 10-point increase in the scale was reported.
DISCuSSIOn
Main findings
This systematic review identified 11 studies evaluating 
10 tools for the prediction of future self-harm/suicide 
attempt in adolescent patients. Of these 11 studies, four 
attempted to develop a predictive model using the tools, 
while seven evaluated the tools as standalone instruments.
This review found there is a wide variation in the setting, 
population, outcome measure, length of follow-up and 
length and content of the tools in use. The variation was 
apparent in the predictive ability reported across the tools. 
The studies reporting predictive validity statistics varied 
greatly in results, for example, the SHQ had high sensi-
tivity (94.7%) and low positive predictor value (25.4%),42 
whereas the SIQ had low sensitivity (27.3%) and high 
positive predictor value (85.7%).36 It could be argued 
that a tool with higher sensitivity would be best suited for 
use in this population, to ensure that all those at risk are 
identified and offered treatment. However, this would 
cause issues with overtreatment and not be the best use 
of resources as the high sensitivity comes with low positive 
predictor values.
This finding of variation in predictive ability implies 
these tools are not sufficiently accurate to be used as 
standalone predictors of future risk of self-harm/
suicide in adolescent populations, mirroring the find-
ings of other reviews in adult populations.3 25–27 This 
adolescent review and the other adult population 
reviews demonstrate there is insufficient evidence for 
use of such tools as the only component of a risk assess-
ment, despite their widespread use for this purpose in 
clinical practice.21
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Methodological limitations
Due to the high heterogeneity between included studies, 
specifically in terms of setting, population and length and 
content of tools used, no meta-analyses were conducted. 
Despite this, a wide range of data has been presented for 
the studies. Data were presented for each tool by outcome, 
and then compared by outcome measure reported where 
possible.
Also, use of the tools in differing populations and use 
of different outcome measures made comparing results 
impossible in studies reporting outcome measures such 
as HR and OR. For example, Horwitz et al39 evaluated 
the severity subscale of the C-SSRS, as did Posner et al,43 
however, Horwitz used the subscale on a continuous basis, 
whereas Posner dichotomised the scores, meaning they 
were not directly comparable. The reporting of results 
using different measures is a known difficulty commonly 
encountered in systematic reviews evaluating diagnostic/
predictive methods.46 Very few studies reported all the 
metrics required for risk prediction.
Despite these limitations, the review has shown that 
multiple scales are in use for adolescent patients and 
that there is lack of consistency of practice. Additionally, 
the evidence from this review demonstrates that tools 
for adolescents have the same issues as tools for adults in 
terms of varying greatly in length and content.22–24 47–50
Implications of evidence
There are difficulties in drawing conclusions regarding 
the clinical significance of results and implications of 
the evidence from this review. First, the outcome data 
presented for each tool does not clearly translate into 
individual patient consequence or benefit.
Second, the very different settings the tools were evalu-
ated in (eg, inpatient units, home treatment settings and 
emergency departments) means that results would not be 
transferable between these settings and the differing clin-
ical populations within.
Third, some of the tools used and models developed 
are not practical for routine clinical use, particularly in an 
emergency department setting. For example, the model 
developed by Chitsabesan et al36 requires four sepa-
rate tools to be administered to both parent and child, 
and the subsequent scores to be used within a formula. 
This would clearly require refinement as it is currently a 
complex and time consuming process.
While the main aim of the review was to evaluate the 
ability of risk assessment tools to predict future episodes 
of suicide or self-harm, several other issues were identi-
fied that merit further investigation.
First, as seen in online supplemental appendix 2, the 
tools specific to self-harm/suicide vary greatly in content 
assessed. For example, seven out of these eight tools assess 
suicidal ideation, however, only two assess previous self-
harm. As there is known to be a strong association between 
suicide and previous self-harm,6 8 9 it seems surprising that 
only a minority of tools assess this important risk factor. 
Further primary research evaluating tool content and 
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Table 3 HR, OR, AUC results
Outcome: Future suicide attempt
Scale/tool Subscale/subgroup
(if applicable)
How score from 
scale/tool used
Outcome 
measure
Value 95% CI P value Study ID
BHS   Continuous 
measure (5-point 
increment)
Unadjusted 
HR
1.51 1.22 to 1.87 <0.001 King et al41
CDRS-R   Continuous 
measure 
(10-point 
increment)
Unadjusted 
HR
1.29 1.10 to 1.52 <0.001 King et al41
  C-SSRS   Dichotomised 
(with/without 
ideation)
Adjusted HR 1.50 1.24 to 1.81 <0.001 Czyz et al37
Dichotomised 
(with/without 
ideation)
AUC 0.74 n/a <0.001 Czyz et al37
Continuous 
measure
(1 SD increment)
Unadjusted 
OR
1.45 1.07 to 1.98 0.02 Posner et al43
Intensity subscale, 
ideators
Continuous 
measure
(1-point 
increment)
Adjusted OR 1.15 1.03 to 1.29 <0.05 Horwitz 
(2015)39
Continuous 
measure (1-point 
increment)
Unadjusted 
OR
1.10 0.97 to 1.28 >0.05 Gipson 
(2015)38
Intensity subscale Continuous 
measure (1-point 
increment)
Unadjusted 
OR
1.09 1.01 to 1.17 0.02 Gipson 
(2015)38
  Severity subscale Continuous 
measure (1-point 
increment)
Adjusted OR 1.51 1.24 to 1.84 <0.001 Horwitz 
(2015)39
Continuous 
measure (1 SD 
increment)
Unadjusted 
OR
1.43 0.99 to 2.05 0.05 Posner 
(2011)43
Continuous 
measure (1-point 
increment)
Unadjusted 
OR
1.34 0.99 to 1.80 0.06 Gipson 
(2015)38
Severity subscale, 
CSHF reference 
standard
Dichotomised 
(with/without 
intent)
Unadjusted 
OR
3.26 1.02 to 10.45 0.047 Posner 
(2011)43
Severity subscale, 
SEB reference 
standard
Dichotomised 
(with/without 
intent)
Unadjusted 
OR
3.85 1.07 to 13.86 0.039 Posner 
(2011)43
SAESRS   Continuous 
measure
AUC 0.79 n/a <0.001 Czyz (2016)37
Scale/tool Subscale/subgroup
(if applicable)
How score from 
scale/tool used
Outcome 
measure
Value 95% CI P value Study ID
SAESRS 
and 
C-SSRS
  Continuous 
measure
Adjusted HR 0.94 0.90 to 0.97 0.001 Czyz (2016)37
Continuous 
measure
AUC 0.8 n/a <0.001 Czyz (2016)37
Continued
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Outcome: Future suicide attempt
  SIQ   Dichotomised 
(high/low 
suicidal ideation)
Adjusted HR 1.01 1.00 to 1.02 >0.05 (NS) Yen (2013)44
Dichotomised 
(high/low 
suicidal ideation)
Unadjusted 
HR
1.01 1.00 to 1.02 <0.05 Yen (2013)44
  SIQ-JR   Continuous 
measure 
(10-point 
increment)
Adjusted HR 1.23 1.08 to 1.40 0.003 King (2010)41
Continuous 
measure 
(10-point 
increment)
Unadjusted 
HR
1.3 1.14 to 1.48 <0.001 King (2010)41
Continuous 
measure (1-point 
increment)
Relative risk 0.93 Not stated Not stated King (2014)40
Outcome: Future self-harm
Scale/tool Subscale/subgroup How score from 
scale/tool used
Outcome 
measure
Value 95% CI P value Study ID
SI-IAT   Continuous 
measure
Adjusted OR 3.10 0.39 to 9.94 >0.05 Cha (2016)35
SITBI   Dichotomised
(high/low 
likelihood of 
repetition)
Adjusted OR 1.82 1.25 to 2.65 0.002 Cha (2016)35
AUC, area under the curve; BHS, Beck Hopelessness Scale; CDRS-R, Children’s Depression Rating Scale-Revised; CSHF, Columbia Suicide 
History Form; C-SSRS, Columbia-Suicide Severity Rating Scale; SAESRS, Self-Assessed Expectations of Suicide Risk Scale; SEB, Suicide 
Evaluation Board; SI-IAT, Self-Injury Implicit Association Test; SIQ, Suicide Ideation Questionnaire; SIQ-JR, Suicide Ideation Questionnaire-
Junior; SITBI, Self-Injurious Thoughts and Behaviours Interview.
Table 3 Continued
identifying predictive risk factors would be beneficial. 
Currently, available evidence is limited by dataset size and 
the populations included, for example, validation of tools 
on community populations rather than clinical ones.
Related to this is how the answers to the questions asked 
by the tools are used in predicative analysis. For example, 
the SHQ evaluated by Ougrin and Boege,42 consists of 
three initial screening questions that everyone is asked 
establishing the presence of self-harm/suicidal ideation, 
and then a further 12 questions exploring self-harm for 
those who give a positive response to the initial three. 
The analysis conducted by Ougrin and Boege, however, 
only used the first three questions to classify patients into 
positive/negative, and the second section of 12 questions 
was not used. As a result, the basis of classification in this 
study was effectively history of self-harm/suicidal ideation, 
rather than the use of the tool’s questions about self-harm 
to stratify risk and predict which patients would go on to 
repeat self-harm. Further analysis of this tool with regard 
to the questions asked in each section would be beneficial 
to explore the predicative ability of this additional data 
collected.
Second, no distinction was found about whether the 
tools in use were for patients presenting with self-harm/
suicide attempt for the first time, or those presenting with 
repeat events. As some tools asked about previous self-
harm/suicide attempts, this was perhaps being taken into 
account, but research exploring whether these patient 
groups have the same risk factors and how previous events 
can modify them, would be useful to understand further 
how to predict and prevent this behaviour, and determine 
whether separate assessments would be appropriate.
Third, Czyz et al37 explored self-rated suicide risk, as 
opposed to that rated through tools. They found that asking 
adolescents to self-rate their risk of suicide was more accu-
rately predictive of future suicide attempts, and this was of 
particular relevance in busy emergency departments with 
time pressures. This was the only study exploring self-rated 
risks, however, and more primary studies are required to 
explore further the use of self-rating in predicting future 
risk. This could have important implications for changing 
practice with regard to how suicide risk is assessed.
Fourth, this review attempted to explore the use of prog-
nostic models in self-harm/suicide prediction, however, 
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due to poor reporting and models only being in the early 
stages of development, this was not really possible in 
any great depth. The four studies that reported model 
development were difficult to understand from a model-
ling point of view. Methods were not explicitly stated 
making it hard to comprehend how analyses had been 
conducted, confounding factors were either not identi-
fied or methods for addressing them were not stated, and 
lack of full reporting meant that carrying out a detailed 
quality appraisal was not possible. Future work should 
build on these early modelling studies to further develop 
them to the later stages of internal and external valida-
tion and impact studies, and it is imperative that future 
studies should be reported fully.
COnCluSIOn
This review is the first to explore the use of tools to predict 
future self-harm/suicide attempts in an adolescent popu-
lation. It has shown that the current limited amount of 
primary evidence means at present no individual tool can 
be identified as performing better than another or is a suffi-
ciently accurate predictor of self-harm/suicide risk. The use 
of tools in prediction models is at an early stage and further 
research is warranted to develop these further. Risk assess-
ment tools should only be used as part of a wider compre-
hensive assessment, assessing more than just the risk of 
repetition. This reflects current standard practice in the 
UK, where National Institute for Health and Care Excel-
lence guidelines recommend thorough psychosocial needs 
assessment focused on patient needs rather than risk.18–20
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